Figure (3f0ba71a 6f2a 460e 85da 117dead61f52 01)
Triamterene And Hydrochlorothiazide Tablet
Product Images NDC 70771-1361
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Triamterene And Hydrochlorothiazide (NDC 70771-1361). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure (3f0ba71a 6f2a 460e 85da 117dead61f52 02)
Figure (3f0ba71a 6f2a 460e 85da 117dead61f52 03)
This appears to be a medication label containing the names of two drugs - Triamterene and Hydrochlorothiazide. The label mentions the strength of Hydrochlorothiazide to be 25mg. The tablets are required to be protected from light and kept in a tightly closed container. The medication is manufactured by Zydus and for prescription-only use. A note on the label advises not to keep the medication accessible to children.*
Figure (3f0ba71a 6f2a 460e 85da 117dead61f52 04)
Triamterene and Hydrochlorothiazide are two drugs that are mentioned in this text. In addition, there is some prescribing information about Hydrochlorothiazide tablets, USP 50mg. The tablets should be stored at a temperature between 20° to 25°C and should be protected from light. It is recommended to dispense the tablets in a light-resistant container with a child-resistant closure. The manufacturer of the tablets is Cadia Healthcare Ltd, located in Ahmedabad, India.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
